{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T22:25:42Z","timestamp":1744842342377},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,10,6]],"date-time":"2016-10-06T00:00:00Z","timestamp":1475712000000},"content-version":"vor","delay-in-days":968,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1093\/ndt\/gft524","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T02:10:12Z","timestamp":1392257412000},"page":"809-822","source":"Crossref","is-referenced-by-count":30,"title":["Distinct immunologic effects of different intravenous iron preparations on monocytes"],"prefix":"10.1093","volume":"29","author":[{"given":"Lisa H.","family":"Fell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam M.","family":"Zawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyrill S.","family":"Rogacev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Fliser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar H.","family":"Heine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,2,11]]},"reference":[{"key":"key\n\t\t\t\t20170518092705_GFT524C1","first-page":"279","article-title":"KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","author":"Group KDIGOKAW","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"key\n\t\t\t\t20170518092705_GFT524C2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518092705_GFT524C3","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518092705_GFT524C4","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518092705_GFT524C5","doi-asserted-by":"crossref","first-page":"248430","DOI":"10.1155\/2012\/248430","article-title":"Utilization patterns of IV iron and erythropoiesis stimulating agents in anemic chronic kidney disease patients: a multihospital study","volume":"2012","author":"Joshi","year":"2012","journal-title":"Anemia"},{"key":"key\n\t\t\t\t20170518092705_GFT524C6","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1681\/ASN.2005040423","article-title":"Time-dependent associations between iron and mortality in hemodialysis patients","volume":"16","author":"Kalantar-Zadeh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092705_GFT524C7","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2007-05-090019","article-title":"Autocrine formation of hepcidin induces iron retention in human monocytes","volume":"111","author":"Theurl","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518092705_GFT524C8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.amjmed.2008.07.012","article-title":"Individualized treatment for iron-deficiency anemia in adults","volume":"121","author":"Alleyne","year":"2008","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170518092705_GFT524C9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1681\/ASN.2006091034","article-title":"Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients\u2019 Response to IV Iron with Elevated Ferritin (DRIVE) Study","volume":"18","author":"Coyne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092705_GFT524C10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejpb.2011.03.016","article-title":"A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications","volume":"78","author":"Jahn","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"key\n\t\t\t\t20170518092705_GFT524C11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/089686080802800210","article-title":"Intravenous iron sucrose in peritoneal dialysis patients with renal anemia","volume":"28","author":"Li","year":"2008","journal-title":"Perit Dial Int"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20170518092705_GFT524C12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2362.2002.0320s1036.x","article-title":"Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion","volume":"32","author":"Kooistra","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"key\n\t\t\t\t20170518092705_GFT524C13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbagen.2011.07.014","article-title":"Non-transferrin bound iron: a key role in iron overload and iron toxicity","volume":"1820","author":"Brissot","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20170518092705_GFT524C14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10534-011-9409-6","article-title":"Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose","volume":"24","author":"Pai","year":"2011","journal-title":"Biometals"},{"key":"key\n\t\t\t\t20170518092705_GFT524C15","first-page":"419","article-title":"The effect of maximum storage on iron status, oxidative stress and antioxidant protection in paediatric packed cell units","volume":"11","author":"Collard","year":"2013","journal-title":"Blood Transfus"},{"key":"key\n\t\t\t\t20170518092705_GFT524C16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00041552-200401000-00013","article-title":"Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension","volume":"13","author":"Vaziri","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t20170518092705_GFT524C17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000339285","article-title":"Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes","volume":"36","author":"Ichii","year":"2012","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20170518092705_GFT524C18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1681\/ASN.V94655","article-title":"Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency","volume":"9","author":"Patruta","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092705_GFT524C19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/ndt\/gfq483","article-title":"Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients","volume":"26","author":"Sonnweber","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518092705_GFT524C20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.bbagen.2008.08.006","article-title":"Iron metabolism in the anemia of chronic disease","volume":"1790","author":"Weiss","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20170518092705_GFT524C21","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518092705_GFT524C22","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1182\/blood-2011-01-326827","article-title":"SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset","volume":"118","author":"Zawada","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518092705_GFT524C23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/eurheartj\/ehq371","article-title":"CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease","volume":"32","author":"Rogacev","year":"2011","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170518092705_GFT524C24","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/ndt\/gft062","article-title":"Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"28","author":"Bailie","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518092705_GFT524C25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease","volume":"28","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518092705_GFT524C26","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ki.1995.132","article-title":"Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors","volume":"47","author":"Harnett","year":"1995","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518092705_GFT524C27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1681\/ASN.2005090997","article-title":"Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients","volume":"17","author":"Regidor","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092705_GFT524C28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/ajkd.2002.33917","article-title":"Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury","volume":"40","author":"Zager","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518092705_GFT524C29","first-page":"9","article-title":"Use of intravenous iron supplementation in chronic kidney disease: an update","volume":"7","author":"Macdougall","year":"2013","journal-title":"Iran J Kidney Dis"},{"key":"key\n\t\t\t\t20170518092705_GFT524C30","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","article-title":"The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF","volume":"168","author":"Belge","year":"2002","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170518092705_GFT524C31","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/ndt\/gfr711","article-title":"Effects of intravenous iron on mononuclear cells during the haemodialysis session","volume":"27","author":"Martin-Malo","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20170518092705_GFT524C32","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.imbio.2012.07.001","article-title":"Monocyte heterogeneity in human cardiovascular disease","volume":"217","author":"Zawada","year":"2012","journal-title":"Immunobiology"},{"key":"key\n\t\t\t\t20170518092705_GFT524C33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1755.2003.00125.x","article-title":"High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity","volume":"64","author":"Deicher","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518092705_GFT524C34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics3010012","article-title":"The pharmacokinetics and pharmacodynamics of iron preparations","volume":"3","author":"Geisser","year":"2011","journal-title":"Pharmaceutics"},{"key":"key\n\t\t\t\t20170518092705_GFT524C35","first-page":"43","article-title":"Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease","volume":"6","author":"Nordfjeld","year":"2012","journal-title":"Drug Des Devel Ther"},{"key":"key\n\t\t\t\t20170518092705_GFT524C36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpba.2013.08.005","article-title":"Structural characterization of iron oxide\/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD)","volume":"86","author":"Futterer","year":"2013","journal-title":"J Pharm Biomed Anal"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170518092705_GFT524C37","first-page":"S93","article-title":"Structure, chemistry, and pharmacokinetics of intravenous iron agents","volume":"15","author":"Danielson","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518092705_GFT524C38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.beha.2004.10.003","article-title":"LPI-labile plasma iron in iron overload","volume":"18","author":"Cabantchik","year":"2005","journal-title":"Best Pract Res Clin Haematol"},{"key":"key\n\t\t\t\t20170518092705_GFT524C39","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2004-02-0630","article-title":"Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded beta-thalassemia\/HbE patients treated with an oral chelator","volume":"104","author":"Pootrakul","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170518092705_GFT524C40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00775-007-0297-8","article-title":"Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera","volume":"13","author":"Evans","year":"2008","journal-title":"J Biol Inorg Chem"},{"key":"key\n\t\t\t\t20170518092705_GFT524C41","volume-title":"Iron Therapy with Special Emphasis on Intravenous Administration","author":"Chrichton","year":"2008"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/29\/4\/809\/17172149\/gft524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T13:23:44Z","timestamp":1648301024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gft524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,11]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,2,11]]},"published-print":{"date-parts":[[2014,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gft524","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,11]]}}}